Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial

Published:2012-11 Issue:11 Volume:11 Page:942-950
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Hill Michael D,Martin Renee H,Mikulis David,Wong John H,Silver Frank L,terBrugge Karel G,Milot Geneviève,Clark Wayne M,MacDonald R Loch,Kelly Michael E,Boulton Melford,Fleetwood Ian,McDougall Cameron,Gunnarsson Thorsteinn,Chow Michael,Lum Cheemun,Dodd Robert,Poublanc Julien,Krings Timo,Demchuk Andrew M,Goyal Mayank,Anderson Roberta,Bishop Julie,Garman David,Tymianski Michael

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference39 articles.

1. The bitterest pill;Nature,2006

2. 1026 experimental treatments in acute stroke;O'Collins;Ann Neurol,2006

3. Is it time to definitely abandon neuroprotection in acute ischemic stroke?;Sacchetti;Stroke,2008

4. Can molecular and cellular neuroprotection be translated into therapies for patients? yes, but not the way we tried it before;Tymianski;Stroke,2010

5. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain;Cook;Nature,2012

Cited by 345 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke: Evolution of newer treatment modalities for acute ischemic stroke;World Journal of Clinical Cases;2024-10-06

2. Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options;International Journal of Molecular Sciences;2024-07-16

3. New Perspectives in Neuroprotection for Ischemic Stroke;Neuroscience;2024-07

4. Role of Neuroprotective Approaches in the Recanalization Era;Stroke;2024-07

5. Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): Rationale and Design of a Randomized Trial;2024-06-13